Increased osmotic and mechanical fragility of the erythrocytes is a consistent finding in patients with hereditary spherocytosis, although in a few individuals it is necessary to incubate the cells at 370 C. for 24 hours before the otherwise latent abnormality becomes demonstrable. Splenectomy will correct the hemolytic process of hereditary spherocytosis despite the continuing production of abnormally fragile cells by the patient. The spleen is, therefore, essential in the destruction of the intrinsically defective erythrocytes. In the peripheral blood of some individuals with this disease a "double population" of cells exists. One component consists of more markedly fragile cells that are not present after splenectomy and must, therefore, have been related to the presence of the spleen.
The present study was undertaken to investigate the changes in osmotic and mechanical fragility accompanying in vivo erythrocyte aging and splenic sequestration and to elucidate the source and fate of the more markedly fragile group of red cells found in some patients.
Advantage was taken of the increased erythropoiesis in patients with hereditary spherocytosis prior to splenectomy to label in vivo with Fe59 the new red cells produced during a short time span, thereby obtaining an identifiable group of cells of known age. Using techniques that will be described, it was possible to differentiate these isotopically-labeled cells from the other cells in the peripheral circulation and to compare their char-acteristics to those of the general population. The changes in osmotic and mechanical fragility occurring in these labeled red cells during in vivo aging and splenic sequestration were followed. In addition, erythrocytes were recovered from the spleen at the time of splenectomy and reinjected into the patient's peripheral circulation. The post-splenectomy survival and changes in osmotic and mechanical fragility of these cells, labeled with Cr51, were followed and distinguished from the cells of the general population.
METHODS
Routine hematologic studies were performed by standard methods (1) . Autohemolysis was determined by the method of Selwyn and Dacie (2) as modified by Young, Izzo, Altman and Swisher (3) . Erythrocyte osmotic fragility tests were done as described by Emerson and associates (4) and the osmotic fragility of the labeled cells was distinguished from that of the general population by the following modification of this method. The volume of each saline solution was increased to 3 ml., and 0.3 ml. of defibrinated whole blood was added to each tube. These were then centrifuged, decanted and the hemoglobin content of 0.5 ml. of the supernatant solution determined in a Beckman (Model B) spectrophotometer. The remainder of the supernatant was transferred to a calibrated isotope counting tube and the radioactivity determined in a low background, well-type scintillation counter (Tracerlab). Sufficient counts were obtained to give a statistical error of ± 3 per cent or less. As a blank, 0.3 ml. of the defibrinated whole blood was suspended in hypertonic saline (1.25 Gm. NaCl per 100 ml.) and the radioactivity found in this supernatant after centrifugation was subtracted from that obtained for the other samples. The (Figure 4) . Studies of osmotic fragility similar to those described above were performed on this patient and the results are presented in Figure 5 . In an effort to diminish the reutilization of Fe59 from destroyed red cells in further red cell production, a relatively large dose of nonisotopic iron was administered beginning on Day 11 of the study. The results of the mechanical fragility studies on this patient are presented in the upper half of Figure 3 . As in the previous study, the mechanical fragility of the labeled cells was initially low and then gradually increased, eventually becoming slightly greater than that of the general cell population. The survival of these Cr51-labeled, spleen-drip red cells is presented in Figure 8 . fused red cells were removed from the circulation within 48 hours; the remaining cells had a normal life span of 100 to 120 days. Neither of these patients showed any significant blood loss postoperatively and on follow-up studies over a period of months, both patients have shown the anticipated good clinical response.
DISCUSSION
The clinical picture and pathologic physiology of hereditary spherocytosis have been reviewed recently in some detail by Dacie (12) and Young (13) . Only a brief outline will be presented here of the erythrocyte abnormalities and of the role of the spleen in the hemolytic process. The relationship of these two factors, the abnormal red cell and the spleen, has been most concisely demonstrated in a study of red cell survival by Emerson (14) . He showed that normal red cells had a normal survival in a patient with hereditary spherocytosis, but that the patient's red cells were incapable of normal survival in a recipient except in the absence of a spleen. Although patients with hereditary spherocytosis characteristically have an enlarged spleen, there is no primary abnormality of the spleen, since it has been amply demonstrated both in vivo and in vitro that a spleen from a patient with hereditary spherocytosis and one from a normal individual will both selectively remove perfused spherocytic red cells but will not selectively remove normal red cells. Although maturing erythrocytes in the patient's bone marrow may show some minor shape changes, they evidently become more abnormal in shape shortly after release into the peripheral circulation (12) . (17), who have shown that fragile cells of this type are found in the spleen pulp and they are not present in the peripheral blood of patients after splenectomy.
In the present study an identifiable group of spherocytic red cells was produced in patients with hereditary spherocytosis by in vivo labeling with Fe59. It is well established that iron administered in this fashion is incorporated only into new red cells and not into older cells. However, when the red cell containing Fe59 is destroyed, the iron is reutilized for new cell production. In an individual with normal red cell survival and normal iron metabolism, no reutilization would occur for 100 to 120 days. Red cells were rapidly being destroyed in the patients in the present study so that Fe59 was, to some degree, being incorporated repeatedly into new cells. This fact limits the usefulness of this technique for studying the cells for a prolonged period of time. Despite this objection it was possible to demonstrate progressive and significant changes in fragility of the new red cells and to follow them for approximately 30 days. Estimation of Fe59 incorporation into peripheral red cells by the usual techniques indicated a utilization of 65 per cent in Case 1 and 80 per cent in Case 2. This undoubtedly does not represent the true maximum utilization of the isotope for hemoglobin labeling since red cells containing Fe59 were being continuously sequestered in the spleen and therefore, removed from the peripheral circulation.
The osmotic fragility of the new red cells was found to be similar to the fragility of the majority of the cells in the peripheral blood. Of particular interest is the fact that none of the new erythrocytes was as osmotically fragile as some of the "conditioned" cells in the patient's peripheral blood. Thus, it is possible from this study to get some idea of the time required for the conditioning process. This would appear to be at least 10 days. From the present evidence it is impossible to say whether the cells are trapped in the spleen for the full period -or the conditioning process is the result of recirculation or repeated short episodes of stagnation in the spleen.
Other investigators have studied the changes in red cell fragilities of dogs and humans without hematologic disease. Cruz, Hahn, Bale and Balfour (18) , and later, Stewart, Stewart, Izzo and Young (19) using dog erythrocytes labeled in vivo with radioactive iron, found that newly formed cells were more osmotically fragile and less mechanically fragile than older cells. As they aged, they became more mechanically fragile, but the osmotic fragility was not significantly altered. In contrast, recent studies in normal man by Simon and Topper (20) and Marks and Johnson (21) have shown that normal young erythrocytes are more resistant to osmotic lysis than older cells.
The observations made after splenectomy on the survival and changes in osmotic and mechanical fragility of the spleen-drip red cells demonstrate that cells with the most marked abnormalities have a short survival and disappear from the circulation within 48 hours. The curves for osmotic fragility changes found in the spleen-drip red cells presented in Figure 6 suggest that there may have been some decrease in osmotic fragility between the time of reinjection of the labeled blood and the first sample studied one hour later. However, it seems more likely that some of the most fragile cells have already been eliminated from the peripheral circulation. Motulsky and co-workers (29) have suggested that the marked increase in osmotic fragility may revert toward normal if the cells are placed in a circulation without a spleen. He transfused red cells labeled with Cr5' from a patient with hereditary spherocytosis, who had not 99 undergone splenectomy and had a cell population consisting of approximately 30 per cent very fragile cells, to the patient's splenectomized brother whose peripheral blood had no very fragile cells. The labeled donor cells showed a gradual decrease in osmotic fragility over a six day period. Since information on survival of these transfused cells is not presented, the observed changes could be due either to a reversible process in the very fragile red cells or to destruction and removal of these cells from the circulation. There is the possibility that the spleen-drip red cells studied in the present experiments had irreversible changes in contrast to the peripheral blood cells studied by Motulsky. He also performed the reverse experiment and transfused labeled red cells from the patient without a spleen into the brother with a spleen. Approximately six days were required for these red cells to show the marked increase in fragility seen in the recipient's own cell population.
The data from the present study demonstrate that in some patients with hereditary spherocytosis there is a progressive increase in osmotic and mechanical fragility of a portion of the red cell population, and that a period of approximately 10 days is required for these changes to reach their maximum from the time the cell first appears in the peripheral circulation. Previous information and the present study certainly implicate the spleen as the source of these very fragile red cells, since they can be found in the splenic pulp and are no longer seen in the peripheral blood after removal of the spleen. From information available at the present time it is impossible to say just how these red cells are conditioned in the spleen. Our experiments on the survival of red cells obtained from the spleen indicate that these very fragile cells have a short life span in the peripheral circulation, less than 48 hours. There was no evidence that the osmotic fragility of these cells reverted toward normal in the absence of the spleen. Therefore, it seems likely that in some patients with hereditary spherocytosis a significant proportion of the red cells is conditioned in the spleen over a period of days and escapes into the peripheral circulation, there undergoing rapid destruction either by the forces of mechanical trauma, osmotic lysis, or undetermined mechanisms. SUM 
MARY
Changes in erythrocyte osmotic and mechanical fragility associated with aging and splenic sequestration were studied in two patients with hereditary spherocytosis by the use of Fe59. New red cells showed some increase in fragility, but after approximately 10 days, conditioned cells with a marked increase in osmotic and mechanical fragility appeared in the peripheral circulation. At the time -of splenectomy, red cells were recovered from the spleen, labeled with Cr5l and reinjected into the patient's peripheral circulation. The conditioned, most fragile cells disappeared rapidly, surviving less than two days; the other red cells, less osmotically and mechanically fragile, had a normal length of survival.
